159 related articles for article (PubMed ID: 24706745)
1. The membrane-anchored serine protease prostasin (CAP1/PRSS8) supports epidermal development and postnatal homeostasis independent of its enzymatic activity.
Peters DE; Szabo R; Friis S; Shylo NA; Uzzun Sales K; Holmbeck K; Bugge TH
J Biol Chem; 2014 May; 289(21):14740-9. PubMed ID: 24706745
[TBL] [Abstract][Full Text] [Related]
2. The CAP1/Prss8 catalytic triad is not involved in PAR2 activation and protease nexin-1 (PN-1) inhibition.
Crisante G; Battista L; Iwaszkiewicz J; Nesca V; Mérillat AM; Sergi C; Zoete V; Frateschi S; Hummler E
FASEB J; 2014 Nov; 28(11):4792-805. PubMed ID: 25138159
[TBL] [Abstract][Full Text] [Related]
3. Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin.
Friis S; Madsen DH; Bugge TH
J Biol Chem; 2016 Feb; 291(6):2577-82. PubMed ID: 26719335
[TBL] [Abstract][Full Text] [Related]
4. Sodium retention in nephrotic syndrome is independent of the activation of the membrane-anchored serine protease prostasin (CAP1/PRSS8) and its enzymatic activity.
Essigke D; Bohnert BN; Janessa A; Wörn M; Omage K; Kalbacher H; Birkenfeld AL; Bugge TH; Szabo R; Artunc F
Pflugers Arch; 2022 Jun; 474(6):613-624. PubMed ID: 35312839
[TBL] [Abstract][Full Text] [Related]
5. Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin.
Szabo R; Lantsman T; Peters DE; Bugge TH
Development; 2016 Aug; 143(15):2818-28. PubMed ID: 27385010
[TBL] [Abstract][Full Text] [Related]
6. The epidermal barrier function is dependent on the serine protease CAP1/Prss8.
Leyvraz C; Charles RP; Rubera I; Guitard M; Rotman S; Breiden B; Sandhoff K; Hummler E
J Cell Biol; 2005 Aug; 170(3):487-96. PubMed ID: 16061697
[TBL] [Abstract][Full Text] [Related]
7. Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase.
List K; Hobson JP; Molinolo A; Bugge TH
J Cell Physiol; 2007 Oct; 213(1):237-45. PubMed ID: 17471493
[TBL] [Abstract][Full Text] [Related]
8. Loss of HAI-2 in mice with decreased prostasin activity leads to an early-onset intestinal failure resembling congenital tufting enteropathy.
Szabo R; Bugge TH
PLoS One; 2018; 13(4):e0194660. PubMed ID: 29617460
[TBL] [Abstract][Full Text] [Related]
9. Kidney-Specific CAP1/Prss8-Deficient Mice Maintain ENaC-Mediated Sodium Balance through an Aldosterone Independent Pathway.
Ehret E; Jäger Y; Sergi C; Mérillat AM; Peyrollaz T; Anand D; Wang Q; Ino F; Maillard M; Kellenberger S; Gautschi I; Szabo R; Bugge TH; Vogel LK; Hummler E; Frateschi S
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743186
[TBL] [Abstract][Full Text] [Related]
10. Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.
Szabo R; Uzzun Sales K; Kosa P; Shylo NA; Godiksen S; Hansen KK; Friis S; Gutkind JS; Vogel LK; Hummler E; Camerer E; Bugge TH
PLoS Genet; 2012; 8(8):e1002937. PubMed ID: 22952456
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation.
Netzel-Arnett S; Currie BM; Szabo R; Lin CY; Chen LM; Chai KX; Antalis TM; Bugge TH; List K
J Biol Chem; 2006 Nov; 281(44):32941-5. PubMed ID: 16980306
[TBL] [Abstract][Full Text] [Related]
12. Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease.
Sugitani Y; Nishida A; Inatomi O; Ohno M; Imai T; Kawahara M; Kitamura K; Andoh A
J Gastroenterol; 2020 Apr; 55(4):408-417. PubMed ID: 31916038
[TBL] [Abstract][Full Text] [Related]
13. Zymogen-locked mutant prostasin (Prss8) leads to incomplete proteolytic activation of the epithelial sodium channel (ENaC) and severely compromises triamterene tolerance in mice.
Essigke D; Ilyaskin AV; Wörn M; Bohnert BN; Xiao M; Daniel C; Amann K; Birkenfeld AL; Szabo R; Bugge TH; Korbmacher C; Artunc F
Acta Physiol (Oxf); 2021 May; 232(1):e13640. PubMed ID: 33650216
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the serine protease CAP1/Prss8 lead to reduced embryonic viability, skin defects, and decreased ENaC activity.
Frateschi S; Keppner A; Malsure S; Iwaszkiewicz J; Sergi C; Merillat AM; Fowler-Jaeger N; Randrianarison N; Planès C; Hummler E
Am J Pathol; 2012 Aug; 181(2):605-15. PubMed ID: 22705055
[TBL] [Abstract][Full Text] [Related]
15. PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1/Prss8 expression in mouse skin.
Frateschi S; Camerer E; Crisante G; Rieser S; Membrez M; Charles RP; Beermann F; Stehle JC; Breiden B; Sandhoff K; Rotman S; Haftek M; Wilson A; Ryser S; Steinhoff M; Coughlin SR; Hummler E
Nat Commun; 2011 Jan; 2():161. PubMed ID: 21245842
[TBL] [Abstract][Full Text] [Related]
16. Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT).
Chen LM; Verity NJ; Chai KX
BMC Cancer; 2009 Oct; 9():377. PubMed ID: 19849847
[TBL] [Abstract][Full Text] [Related]
17. Liver-Specific Overexpression of Prostasin Attenuates High-Fat Diet-Induced Metabolic Dysregulation in Mice.
Sekine T; Takizawa S; Uchimura K; Miyazaki A; Tsuchiya K
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361079
[TBL] [Abstract][Full Text] [Related]
18. The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling.
Uchimura K; Hayata M; Mizumoto T; Miyasato Y; Kakizoe Y; Morinaga J; Onoue T; Yamazoe R; Ueda M; Adachi M; Miyoshi T; Shiraishi N; Ogawa W; Fukuda K; Kondo T; Matsumura T; Araki E; Tomita K; Kitamura K
Nat Commun; 2014 Mar; 5():3428. PubMed ID: 24614850
[TBL] [Abstract][Full Text] [Related]
19. A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation.
Friis S; Uzzun Sales K; Godiksen S; Peters DE; Lin CY; Vogel LK; Bugge TH
J Biol Chem; 2013 Jun; 288(26):19028-39. PubMed ID: 23673661
[TBL] [Abstract][Full Text] [Related]
20. The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.
Tamir A; Gangadharan A; Balwani S; Tanaka T; Patel U; Hassan A; Benke S; Agas A; D'Agostino J; Shin D; Yoon S; Goy A; Pecora A; Suh KS
J Ovarian Res; 2016 Mar; 9():20. PubMed ID: 27036110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
